Nesiritide: first use in India.
Pediatric Cardiology & Congenital Cardiac Surgery, Indraprastha Apollo Hospital, New Delhi, India.Indian Heart Journal (Impact Factor: 0.17). 01/2009; 61(4):371-2.
[Show abstract] [Hide abstract]
- "Nesiritide use has been limited in India. However, the successful first usage has been documented in a recent publication. "
ABSTRACT: Natriuretic peptides (NPs) are hormones which are mainly secreted from heart and have important natriuretic and kaliuretic properties. There are four different groups NPs identified till date [atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), C-type natriuretic peptide (CNP) and dendroaspis natriuretic peptide, a D-type natriuretic peptide (DNP)], each with its own characteristic functions. The N-terminal part of the prohormone of BNP, NT-proBNP, is secreted alongside BNP and has been documented to have important diagnostic value in heart failure. NPs or their fragments have been subjected to scientific observation for their diagnostic value and this has yielded important epidemiological data for interpretation. However, little progress has been made in harnessing the therapeutic potential of these cardiac hormones.10/2011; 15 Suppl 4(Suppl4):S345-53. DOI:10.4103/2230-8210.86978
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.